1 2 3 4 5

читать далее ... 827-838. 3. HOPE study investigators Effects of an angiotensin-converting-emyme inhibitor. ramipril, on cardiovascular events in high-risk patients. 1\1 EngI J Med 2000:342' 145-53. 4. Estasio RO. Jeflers BW. Hiatt W, et al. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. ABCD Study. l\l Eng J Med 1998: 338: 645-52. 5. Kaplan M. Metabolic Aspects of Hypertension. Science press 1994. London. 6. Pepine CJ. Handberg EM, Rhonda M. Cooper, at al. A Calcium Antagonist vs a Non-Calcium Antagonist Hypertension Tretmenf Strategy for Patients With Coronary Artery Disease The International Verapamil SR/Trandolapril Study (INVEST): A Randomized Controlled Trial. JAMA December 3, 2003: N"21 (Vol 290):2805-61. 7. The ALLHAT Officers and Coordinators Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA 2002:288:2981-97. 8. Dahlof В, Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002,359:995-1003. 9. Schiffrin EL, Hayoz D. Angiotension II Receptor antagonists. Edited by Murray Epstein and Hans R. Brunner. Hanley Belfus, INC Philadelphia. 2001:279- 289 10. Taddei S. VirdisA, Chiadoni L. Salvetti A. The pivotal role of endofelium in hypertension. Medicographia. Issue 59. 1999. Vol 21., Л/о. 1:22-29. 11. CAPPP Hansson L, Lindholm LH, Niskanen L et al: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the captopril prevention project (CAPPP) randomized trial. Lancet 1999:353:611-6. 12. Lithell H: Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 1991, 14:203-209. 13. Lithell H: Insulin resistance and cardiovascular drugs. Clin Exper Hyper [A] 1992. 14: 151-162. 14. Pollarre T. Lithell H, Berne С: A comparison of the effects of hydrochlorothiaz/de and captopril on glucose and lipid metabolism in patients with hypertension. /V EngI J Med 1989,321:868-871. 15. Berne С: Metabolic effects of ACE inhibitors. J Int Med 1991, 229(suppl 2):119-125.Источник: Небиеридзе Д.В. Русский медицинский журнал. 2005. Т.13. №15. С.992-995